Han W Tun (Han Tun)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Cerebrospinal Fluid

Chronic Lymphocytic Leukemia

Top Venues

Journal of blood medicine

Blood and lymphatic cancer : targets and therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Emily B Wolf, Robin Imperial, Liuyan Jiang, Amit K Agarwal, Han W Tun
Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis. Journal of blood medicine 15 (2024)
Emily B Wolf, Robin Imperial, Liuyan Jiang, Amit K Agarwal, Han W Tun
Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis. Journal of blood medicine 15 (2024)
Marie M Plante, ErinMarie O Kimbrough, Amit K Agarwal, Liuyan Jiang, Kirk Bourgeois, Greta C Stamper, Michael W Stewart, Han W Tun
Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations. Journal of blood medicine 14 (2023)
Jing Wang, Firas Baidoun, Han W Tun, Muhamad Alhaj Moustafa
90 Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases. Blood and lymphatic cancer : targets and therapy 13 (2023)
Lyndsey L Fournier, ErinMarie O Kimbrough, Muhamad Alhaj Moustafa, Ke Li, Madiha Iqbal, Vivek Gupta, Han W Tun
Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy. Journal of blood medicine 14 (2023)
Christina A von Roemeling, Bently P Doonan, Kelena Klippel, Daniel C Schultz, Lan Hoang-Minh, Vrunda Trivedi, Chenglong Li, Rylynn Russell, Siva Rama Raju Kanumuri, Abhisheak Sharma, Han W Tun, Duane A Mitchell
Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
ErinMarie O Kimbrough, Vivek Gupta, Liuyan Jiang, Han W Tun
Successful Anatomy Adapted Therapeutic Management and Genetic Profiling of Primary Pituitary Diffuse Large B-Cell Lymphoma. Blood and lymphatic cancer : targets and therapy 13 (2023)
Jordan Davis, ErinMarie O Kimbrough, Muhamad Alhaj Moustafa, Liuyan Jiang, Vivek Gupta, Ephraim Parent, Han W Tun
Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma. Journal of blood medicine 14 (2023)
Marie M Plante, ErinMarie O Kimbrough, Amit K Agarwal, Liuyan Jiang, Kirk Bourgeois, Greta C Stamper, Michael W Stewart, Han W Tun
Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations. Journal of blood medicine 14 (2023)
Christina A von Roemeling, Bently P Doonan, Kelena Klippel, Daniel C Schultz, Lan Hoang-Minh, Vrunda Trivedi, Chenglong Li, Rylynn Russell, Siva Rama Raju Kanumuri, Abhisheak Sharma, Han W Tun, Duane A Mitchell
Oral IRAK-4 inhibitor CA-4948 is blood-brain barrier penetrant and has single-agent activity against CNS lymphoma and melanoma brain metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jordan Davis, ErinMarie O Kimbrough, Muhamad Alhaj Moustafa, Liuyan Jiang, Vivek Gupta, Ephraim Parent, Han W Tun
Successful CNS-Centric Therapeutic Management and Genomic Profiling of Primary Cranial Vault Diffuse Large B-Cell Lymphoma. Journal of blood medicine 14 (2023)
Karan L Chohan, Jason R Young, Scott Lester, Muhamad Alhaj Moustafa, Allison Rosenthal, Han W Tun, Bradford S Hoppe, Patrick B Johnston, Ivana N Micallef, Thomas M Habermann, Stephen M Ansell
A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome. Blood advances 6 (14) (2022)
Adam M Kase, Catherine Bullock, Ricardo Parrondo, Muhamad Alhaj Moustafa, Madiha Iqbal, K David Li, Ephraim E Parent, Han W Tun
Neuropsychiatric Manifestations of Lymphoma-Associated Cerebral Glucose Hypometabolism Can Be Reversed by Intensive Glucose Supplementation. Blood and lymphatic cancer : targets and therapy 12 (2022)
Jing Wang, Muhamad Alhaj Moustafa, Justin J Kuhlman, Karan Seegobin, Liuyan Jiang, Vivek Gupta, Han W Tun
Intravascular Large B Cell Lymphoma with CNS Involvement Successfully Treated with High-Dose Methotrexate and High-Dose Ara-C Based CNS-Directed Chemoimmunotherapy Alternating with Anthracycline Based Chemoimmunotherapy. Blood and lymphatic cancer : targets and therapy 12 (2022)
ErinMarie O Kimbrough, Liuyan Jiang, Ephraim E Parent, Kirk Bourgeois, Muhamad Alhaj Moustafa, Han W Tun, Madiha Iqbal
Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes. Journal of blood medicine 13 (2022)
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Jing Wang, Vivek Gupta, Han W Tun
Long-Term Survival with Ibrutinib Therapy in Elderly Patients with Newly Diagnosed Primary Central Nervous System Lymphoma. Blood and lymphatic cancer : targets and therapy 12 (2022)
Justin J Kuhlman, Muhamad Alhaj Moustafa, Vivek Gupta, Liuyan Jiang, Han W Tun
Primary Cauda Equina Lymphoma Treated with CNS-Centric Approach: A Case Report and Literature Review. Journal of blood medicine 12 (2021)
Karan Seegobin, Muhamad Alhaj Moustafa, Umair Majeed, Jordan C Ray, Marwan Shaikh, Liuyan Jiang, Han W Tun
Macrophage Activation Led Acute Heart Failure Managed Successfully with Immunosuppression. Journal of blood medicine 12 (2021)
Karan Seegobin, Muhamad Alhaj Moustafa, Liuyan Jiang, Han W Tun
Successful Non-Transplant Treatment of Double Hit Richter Transformation with Long-Term Remission. Blood and lymphatic cancer : targets and therapy 11 (2021)
Justin J Kuhlman, Muhamad Alhaj Moustafa, Liuyan Jiang, Han W Tun
Primary HHV-8 (-) Effusion-Based Non-Germinal Center B Cell Diffuse Large B Cell Lymphoma Successfully Treated with Standard Anthracycline-Based Chemoimmunotherapy. Journal of blood medicine 12 (2021)
Yushi Qiu, Zhimin Li, Frederic Pouzoulet, Prakash Vishnu, John A Copland, Keith L Knutson, Carole Soussain, Han W Tun
Immune checkpoint inhibition by anti-PDCD1 (anti-PD1) monoclonal antibody has significant therapeutic activity against central nervous system lymphoma in an immunocompetent preclinical model. British journal of haematology 183 (4) (2017)